医学
左心室肥大
肾功能
常染色体显性多囊肾病
心脏病学
内科学
血压
肌酐
肾脏疾病
多囊肾病
心室肥大
肾
作者
Robert W. Schrier,Kimberly K. McFann,Ann Johnson,Arlene B. Chapman,Charles L. Edelstein,Godela Brosnahan,Tevfik Ecder,Lyn Tison
出处
期刊:Journal of The American Society of Nephrology
日期:2002-07-01
卷期号:13 (7): 1733-1739
被引量:184
标识
DOI:10.1097/01.asn.0000018407.60002.b9
摘要
ABSTRACT. This study sought to investigate the cardiac and renal effects of rigorous versus standard BP control on autosomal-dominant polycystic kidney disease (ADPKD). A prospective, randomized, 7-yr study was performed to examine the effect of rigorous (<120/80 mmHg) versus standard (135–140/85–90 mmHg) BP control on left ventricular mass index (LVMI) and kidney function in 75 hypertensive ADPKD patients with left ventricular hypertrophy. LVMI was measured by echocardiogram at baseline and at 1 and 7 yr. Renal function was assessed by measuring serum creatinine and 24-h creatinine clearance every 6 mo for 3 yr, then annually for an additional 4 yr. The baseline characteristics were comparable in the two groups. During the study, average mean arterial pressure was 90 ± 5 mmHg for the rigorous group and 101 ± 4 mmHg for the standard group (P < 0.0001). The LVMI decreased by 21% in the standard group and by 35% in the rigorous group. A mixed model longitudinal data analysis revealed that rigorous BP control was significantly more effective in decreasing LVMI (P < 0.01). There was no statistically significant difference in renal function between the two groups. In conclusion, left ventricular hypertrophy, a major cardiovascular risk factor, was decreased to a significantly greater extent by rigorous than standard BP control. This finding has particular clinical importance because cardiovascular complications are the most common cause of death in ADPKD patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI